摘要
背景: 复杂的中枢神经系统(CNS)是由神经细胞和神经胶质细胞组成的。中枢神经系统细胞在损伤后和修复过程中都能再生。Shh-N糖蛋白启动的音猬因子信号通路在中枢神经系统的生长发育和肿瘤发生中起着重要作用。Nkx2.2同源域转录因子是一个效应分子，在正常生长过程中受到Shh的正向调控。在胚胎阶段的神经管模式形成过程中，Nkx2.2是V3领域规范的关键。MBP +寡树突胶质细胞由表达Olig2的祖细胞分化而来。Nx2.2与Olig2在少突胶质细胞中共同表达，对寡树突胶质细胞成熟后期至关重要。 目的: 本文就Nkx2.2转录因子在胶质母细胞瘤发生发展中的作用进行综述。 结论: 通路在寡树突胶质细胞分化过程中起重要作用，Nkx2.2转录因子在寡树突胶质细胞分化成熟过程中起重要作用。有趣的是，Nkx2.2转录因子在Shh信号通路异常的情况下被报告在胶质瘤样本中。提示Nkx2.2表达谱可以作为胶质瘤早期诊断的潜在生物标记。
关键词: 声波刺猬，Nkx2.2，Pax6，Olig2，少突胶质细胞，成胶质细胞瘤。
图形摘要
[1]
Gawlik-rzemieniewska, N.; Bednarek, I. The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells. Cancer Biol. Ther., 2016, 17, 1-10.
[2]
Briscoe, J.; Sussel, L.; Serup, P.; Connor, D. H. Homeobox gene Nkx2 . 2 and Speci ® cation of neuronal identity by graded sonic hedgehog signalling. 1999, 398, 622-627.
[3]
Briscoe, J.; Pierani, A.; Jessell, T.M.; Ericson, J. A homeodomain protein code specifies progenitor cell identity and neuronal fate in the ventral neural tube. Cell, 2000, 101, 435-445.
[4]
Gama, A.M.D.; Geng, Y.; Couto, J.A.; Martin, B.; Boyle, E.A.; Lacoursiere, C.M.; Hossain, A.; Nicole, E.; Barry, B.; Kwiatkowski, D.J. mTOR pathway mutations cause hemimegalencephaly and focal cortical dysplasia alissa. Ann. Neurol., 2016, 77, 720-725.
[5]
Jiang, Y.; Sheng, H.; Meng, L.; Yue, H.; Li, B.; Zhang, A.; Dong, Y. RBM5 inhibits tumorigenesis of gliomas through inhibition of Wnt / β -catenin signaling and induction of apoptosis; Biomed. Central, 2017, pp. 1-8.
[6]
U, J. B.; Ericson, J. The specification of neuronal identity by graded sonic hedgehog signalling. Cell Dev. Biol., 1999, 10, 353-362.
[7]
Shahi, M.H.; Díaz, E. Transcription factor targets as treatment for medulloblastoma; Brain Tumors-Current and Emerging Therapeutic Strategies, 2010, pp. 209-224.
[8]
Shahi, M.H.; Lorente, A.; Castresana, J.S. Hedgehog signalling in medulloblastoma, glioblastoma and neuroblastoma. Oncol. Rep., 2008, 19, 681-688.
[9]
Marigo, V.; Roberts, D.J.; Lee, S.M.; Tsukurov, O.; Levi, T.; Gastier, J.M.; Epstein, D.J.; Gilbert, D.J.; Copeland, N.G.; Seidman, C.E. Cloning, expression, and chromosomal location of SHH and IHH: Two human homologues of the drosophila segment polarity gene hedgehog. Genomics, 1995, 28, 44-51.
[10]
Nüsslein-Volhard, C.; Wieschaus, E. Mutations affecting segment number and polarity in drosophila. Nature, 1980, 287, 795-801.
[11]
Sansom, S.N.; Livesey, F.J. Gradients in the brain: The control of the development of form and function in the cerebral cortex. Cold Spring Harborperspectives Biol., 2009, 1, 1-16.
[12]
Porter, J.A.; Ekker, S.C.; Park, W.J.; Von Kessler, D.P.; Young, K.E.; Chen, C.H.; Ma, Y.; Woods, A.S.; Cotter, R.J.; Koonin, E.V.; Beachy, P.A. Hedgehog patterning activity : Role of a lipophilic modification mediated by the carboxy-terminal autoprocessing domain. 1996, 86, 21-34.
[13]
Pepinsky, R.B. Zeng, C.; Wen, D.; Rayhorn, P.; Baker, D.P.; Williams, K.P.; Bixler, S.A.; Ambrose, C.M.; Garber, E.A.; Miatkowski, K.; Taylor, F.R. Identification of a palmitic acid-modified form of human sonic hedgehog. J. Biol. Chem., 1998, 273, 14037-14045.
[14]
Goodrich, L.V.; Jung, D.; Higgins, K.M.; Scott, M.P. Overexpression of ptc1 inhibits induction of shh target genes and prevents normal patterning in the neural tube. Dev. Biol., 1999, 211, 323-334.
[15]
Stone, D.M.; Hynes, M.; Armanini, M.; Swanson, T.A.; Gu, Q.; Johnson, R.L.; Scott, M.P.; Pennica, D.; Goddard, A.; Phillips, H.; Noll, M. The tumour-suppressor gene patched encodes a candidate receptor for sonic hedgehog. Nature, 1996, 384, 129-134.
[16]
Hahn, H.; Christiansen, J.; Wicking, C.; Zaphiropoulos, P.G.; Chidambaram, A.; Gerrard, B.; Vorechovsky, I.; Bale, A.E.; Toftgard, R.; Dean, M.; Wainwright, B. A mammalian patched homolog is expressed in target tissues of sonic hedgehog and maps to a region associated with developmental abnormalities. J. Biol. Chem., 1996, 271, 12125-12129.
[17]
Yoon, J.W.; Kita, Y.; Frank, D.J.; Majewski, R.R.; Konicek, B.A.; Nobrega, M.A.; Jacob, H.; Walterhouse, D.; Iannaccone, P. Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation. J. Biol. Chem., 2002, 277, 5548-5555.
[18]
Shahi, M.H.; Afzal, M.; Sinha, S.; Eberhart, C.G.; Rey, J. a; Fan, X.; Castresana, J. S. Regulation of sonic hedgehog-GLI1 downstream target genes PTCH1, Cyclin D2, plakoglobin, PAX6 and NKX2.2 and their epigenetic status in medulloblastoma and astrocytoma. BMC Cancer, 2010, 10, 614-634.
[19]
Watada, H.; Mirmira, R.G.; Kalamaras, J.; German, M.S. Intramolecular control of transcriptional activity by the NK2-specific domain in nk-2 homeodomain proteins. Proc. Natl. Acad. Sci. USA, 2000, 97, 9443-9448.
[20]
Bhat, S.; Kabekkodu, S.P.; Varghese, V.K.; Chakrabarty, S.; Mallya, S.P.; Rotti, H.; Pandey, D.; Kushtagi, P.; Satyamoorthy, K. Aberrant gene-specific DNA methylation signature analysis in cervical cancer. Tumour Biol., 2017, 39, 1-16.
[21]
Dayer, D.; Tabar, M.H.; Moghimipour, E.; Tabandeh, M.R.; Ghadiri, A.A.; Bakhshi, E.A.; Orazizadeh, M.; Ghafari, M.A. Sonic hedgehog pathway suppression and reactivation accelerates differentiation of rat adipose-derived mesenchymal stromal cells toward insulin-producing cells. Cytotherapy, 2016, 18, 937-946.
[22]
Mitutsova, V.; Yeo, W.W.Y.; Davaze, R.; Franckhauser, C.; Hani, E-H.; Abdullah, S.; Mollard, P.; Schaeffer, M.; Fernandez, A.; Lamb, N.J.C. Adult muscle-derived stem cells engraft and differentiate into insulin-expressing cells in pancreatic islets of diabetic mice. Stem Cell Res. Ther., 2017, 8, 86-100.
[23]
Kim, Y.; Nirenberg, M. Drosophila NK-homeobox genes. Proc. Natl. Acad. Sci. USA, 1989, 86, 7716-7720.
[24]
Lints, T.J.; Parsons, L.M.; Hartley, L.; Lyons, I.; Harvey, R.P. Nkx-2. 5 : A novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development, 1993, 119, 419-431.
[26]
Hessabi, B.; Schmidt, I.; Walther, R. The homeodomain of Nkx2.2 carries two cooperatively acting nuclear localization signals. Biochem. Biophys. Res. Commun., 2000, 270, 695-700.
[27]
Sun, T.; Dong, H.; Wu, L.; Kane, M.; Rowitch, D.H.; Stiles, C.D. Cross-repressive interaction of the Olig2 and Nkx2.2 transcription factors in developing neural tube associated with formation of a specific physical complex. J. Neurosci., 2003, 23, 9547-9556.
[28]
Briscoe, J. Morphogens, modeling and patterning the neural tube: An interview with james briscoe. BMC Biol., 2015, 13, 1-5.
[29]
Son, H.Y.; Hwangbo, Y.; Yoo, S.K.; Im, S.W.; Kwak, S.J.; Park, M.S.; Kwak, S.H.; Cho, S.W.; Ryu, J.S.; Kim, J.; Jung, Y.S. Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer. Nat. Commun., 2017, 8, 1-12.
[30]
Griesing, S.; Kajino, T.; Tai, M.C.; Liu, Z.; Nakatochi, M.; Shimada, Y.; Suzuki, M.; Takahashi, T. Thyroid transcription factor-1-regulated microRNA-532-5p targets KRAS and MKL2 Oncogenes and induces apoptosis in lung adenocarcinoma cells. Cancer Sci., 2017, 108, 1394-1404.
[31]
Smith, R.; Owen, L.A.; Trem, D.J.; Wong, J.S.; Whangbo, J.S.; Golub, T.R.; Lessnick, S.L. Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing’s sarcoma. Cancer Cell, 2006, 9, 405-416.
[32]
Hung, Y.P.; Fletcher, C.D.M.; Hornick, J.L. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: Imperfect specificity for Ewing Sarcoma. Mod. Pathol., 2016, 29, 370-380.
[33]
Lu, X.; Tang, L.; Li, K.; Zheng, J.; Zhao, P.; Tao, Y.; Li, L-X. Contribution of NKX2-3 polymorphisms to inflammatory bowel diseases: A meta-analysis of 35358 subjects. Sci. Rep., 2014, 4, 1-9.
[34]
Xu, J.H.; Gu, J.Y.; Guo, Y.H.; Zhang, H.; Qiu, X.B.; Li, R.G.; Shi, H.Y.; Liu, H.; Yang, X.X.; Xu, Y.J.; Qu, X.K. Prevalence and spectrum of NKX2-5 mutations associated with sporadic adult-onset dilated cardiomyopathy. Int. Heart J., 2017, 58, 1-9.
[35]
Wang, J.; Zhang, D.F.; Sun, Y.M.; Li, R.G.; Qiu, X.B.; Qu, X.K.; Liu, X.; Fang, W.Y.; Yang, Y.Q. NKX2-6 Mutation predisposes to familial atrial fibrillation. Int. J. Mole. Med., 2014, 34, 1581-1590.
[36]
Wang, J.; Mao, J.H.; Ding, K.K.; Xu, W.J.; Liu, X.Y.; Qiu, X.B.; Li, R.G.; Qu, X.K.; Xu, Y.J.; Huang, R.T.; Xue, S. A novel NKX2.6 mutation associated with congenital ventricular septal defect. Pediatr. Cardiol., 2014, 36, 646-656.
[37]
Qi, Y.; Cai, J.; Wu, Y.; Wu, R.; Lee, J.; Fu, H.; Rao, M.; Sussel, L. Control of oligodendrocyte differentiation by the Nkx2. 2 Homeodomain Transcription Factor. Development, 2001, 128, 2723-2733.
[38]
Tanaka, T.; Yoshida, S. Mechanisms of remyelination : Recent insight from experimental models. Biomol. Concepts, 2014, 5, 289-298.
[39]
Samanta, J.; Kessler, J.A. Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development, 2004, 131, 4131-4142.
[40]
Shimizu, T.; Kagawa, T.; Wada, T.; Muroyama, Y.; Takada, S.; Ikenaka, K. Wnt signaling controls the timing of oligodendrocyte development in the spinal cord. Dev. Biol., 2005, 282, 397-410.
[41]
Park, H-C.; Appel, B. Delta-notch signaling regulates oligodendrocyte specification. Development (Cambridge, England), 2003, 130, 3747-3755.
[42]
Murray, K.; Calaora, V.; Rottkamp, C.; Guicherit, O.; Dubois-dalcq, M. Sonic hedgehog is a potent inducer of rat oligodendrocyte development from cortical precursors in vitro. Mol. Cell. Neurosci., 2002, 19, 320-332.
[43]
Fancy, S.P.J.; Zhao, C.; Franklin, R.J.M. Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol. Cell. Neurosci., 2004, 27, 247-254.
[44]
Douarin, N.M. Le. Oligodendrocyte precursors originate from both the dorsal and the ventral parts of the spinal cord. Neuron, 1995, 15, 1299-1310.
[45]
Fu, H.; Qi, Y.; Tan, M.; Cai, J.; Takebayashi, H.; Nakafuku, M. Dual origin of spinal oligodendrocyte progenitors and evidence for the cooperative role of olig2 and Nkx2. 2 in the control of oligodendrocyte differentiation. Development, 2002, 129, 681-693.
[46]
Affeldt, B.M.; Obenaus, A.; Chan, J.; Pardo, A.C. Region specific oligodendrocyte transcription factor expression in a model of neonatal hypoxic injury. Int. J. Dev. Neurosci., 2017, 61, 1-11.
[47]
Kremer, D.; Cui, Q.L.; Göttle, P.; Kuhlmann, T.; Hartung, H.P.; Antel, J.; Küry, P. CXCR7 is involved in human oligodendroglial precursor cell maturation. PLoS One, 2016, 11, 1-12.
[48]
Tochitani, S.; Hayashizaki, Y. Nkx2.2 antisense RNA overexpression enhanced oligodendrocytic differentiation. Biochem. Biophys. Res. Commun., 2008, 372, 691-696.
[49]
Zhou, Q.; Choi, G.; Anderson, D.J. The bHLH transcription factor olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2. 2. Neuron, 2001, 31, 791-807.
[50]
Rodrigues, G.M.; Gaj, T.; Adil, M.M.; Wahba, J.; Rao, A.T.; Lorbeer, F.K.; Kulkarni, R.U.; Diogo, M.M.; Cabral, J.M.; Miller, E.W.; Hockemeyer, D. Defined and scalable differentiation of human oligodendrocyte precursors from pluripotent stem cells in a 3D culture system. Stem Cell Reports, 2017, 8, 1-14.
[51]
Lee, S.; Lee, B.; Ruiz, E.C.; Pfaff, S.L. Olig2 and Ngn2 function in opposition to modulate gene expression in motor neuron progenitor cells. Gener Dev., 2005, 19, 282-294.
[52]
Holz, A.; Kollmus, H.; Ryge, J.; Niederkofler, V.; Dias, J.; Ericson, J.; Stoeckli, E.T.; Kiehn, O.; Arnold, H-H. The transcription factors Nkx2.2 and Nkx2.9 play a novel role in floor plate development and commissural axon guidance. Development (Cambridge, England), 2010, 137, 4249-4260.
[53]
Ericson, J.; Morton, S.; Kawakami, A.; Roelink, H.; Jessell, T.M. Two critical periods of sonic hedgehog signaling required for the specification of motor neuron identity. Cell, 1996, 87, 661-673.
[54]
Jarrar, W.; Vauti, F.; Arnold, H-H.; Holz, A. Generation of a Nkx2.2(Cre) knock-in mouse line: Analysis of cell lineages in the central nervous system. Differentiation, 2015, 89, 1-7.
[55]
Chow, B.A.Y.; Division, P.D.; Biology, C. Cell cycle control by oncogenes and tumor suppressors : Driving the transformation of normal cells into cancerous cells appropriately drive progression from one cell cycle stage to the next. Nature Education, 2010, 1205, 1-4.
[56]
Hoshino, T.W.C. Review of basic concepts of cell kinetics as applied to brain tumors. J. Neurosurg., 1975, 42, 123-131.
[57]
Dunn, G.P.; Rinne, M.L.; Wykosky, J.; Genovese, G.; Quayle, S.N.; Dunn, I.F.; Agarwalla, P.K.; Chheda, M.G.; Campos, B.; Wang, A. Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev., 2012, 26, 756-784.
[58]
Mattern, R-H.; Read, S.B.; Pierschbacher, M.D.; Sze, C-I.; Eliceiri, B.P.; Kruse, C.A. Glioma cell integrin expression and their interactions with integrin antagonists. Cancer Ther., 2005, 3A, 325-340.
[59]
Shahi, M.H.; Rey, J.A.; Castresana, J.S. The sonic hedgehog-GLI1 signaling pathway in brain tumor development. Expert Opin. Ther. Targets, 2012, 16, 1227-1238.
[60]
Clement, V.; Sanchez, P.; de Tribolet, N.; Radovanovic, I.; Ruiz i Altaba, A. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr. Biol., 2007, 17, 165-172.
[61]
Shahi, M.H.; Farheen, S.; Mariyath, M.P.M.; Castresana, J.S. Potential role of Shh-Gli1-BMI1 signaling pathway nexus in glioma chemoresistance. Tumor Biol., 2016, 37, 15107-15114.
[62]
Balbous, A.; Renoux, B.; Cortes, U.; Milin, S.; Guilloteau, K.; Tripiana, C.; Legigan, T.; Rivet, P.; Boissonnade, O.; Karayan-tapon, L. Selective release of a cyclopamine glucuronide prodrug toward stem-like cancer cell inhibition in glioblastoma. Mol. Cancer Ther., 2014, 13, 2159-2170.
[63]
Song, L.; Wang, W.; Liu, D.I.; Zhao, Y.; He, J.; Wang, X.; Dai, Z.; Zhang, H.; Li, X. Targeting of sonic hedgehog - Gli signaling : A potential therapeutic target for patients with breast cancer. Oncol. Lett., 2016, 12, 1027-1033.
[64]
Han, L.; Ma, J.; Duan, W.; Zhang, L.; Yu, S.; Xu, Q.; Lei, J.; Li, X.; Wang, Z.; Wu, Z. Pancreatic stellate cells contribute pancreatic cancer pain via activation of shh signaling pathway. Oncotarget, 2016, 7, 18146-18158.
Related Books
Frontiers in Clinical Drug Research - Anti-Cancer Agents
NEOPLASIA and FERTILITY
Breast Cancer: Current Trends in Molecular Research
The Evolution of Radionanotargeting towards Clinical Precision Oncology: A Festschrift in Honor of Kalevi Kairemo
Nanotherapeutics for the Treatment of Hepatocellular Carcinoma
Topics in Anti-Cancer Research
Frontiers in Clinical Drug Research - Anti-Cancer Agents
Modern Cancer Therapies and Traditional Medicine: An Integrative Approach to Combat Cancers
Herbal Medicine: Back to the Future
Thrombosis in Cancer: A Medical Professional's Guide to Cancer Associated Thrombosis
Article Metrics
28
3